What Does the Current Evidence Say
NaBPC157 (10 g or 10 ng/kg i.p.) has a prophylactic effect (applied either 1 hour before, or simultaneously with 96% ethanol (1 ml/rat, i.g.)) and a salutary effect (applied 1 hour after ethanol at the maximum of the lesion's development)
It has been extensively characterised in preclinical in-vitro and in-vivo models for its cytoprotective, angiogenic, and anti-inflammatory properties across a range of tissue types
Stable gastric pentadecapeptide BPC 157 vascular and organoprotective effects
The buyer assumes full responsibility for the safe handling, storage, and disposal of this product in accordance with all applicable laws and laboratory safety protocols
Once administered, BPC-157 works by promoting angiogenesis (the formation of new blood vessels), stimulating growth factor expression, and modulating nitric oxide pathways